Source: Medicines & Healthcare Products Regulatory Agency (GB) | Revision Year: 2012 | Publisher: UCB Pharma SA Allée de la Recherche 60 B-1070 Bruxelles Belgium
Cimzia 200 mg solution for injection.
Solution for injection in pre-filled syringe.
Clear to opalescent, colourless to yellow solution. The pH of the solution is approximately 4.7.
Each pre-filled syringe contains 200 mg certolizumab pegol in one ml.
Certolizumab pegol is a recombinant, humanised antibody Fab' fragment against tumour necrosis factor alpha (TNFα) expressed in Escherichia coli and conjugated to polyethylene glycol (PEG).
For the full list of excipients, see section 6.1.
Water for injections
One ml pre-filled syringe (type I glass) with a plunger stopper (bromobutyl rubber), containing 200 mg of certolizumab pegol.
None of the components of the syringe contain latex.
Pack size of 2 syringes and 2 alcohol wipes, and multipack containing 6 (3 packs of 2) pre-filled syringes and 6 (3 packs of 2) alcohol wipes.
Not all pack sizes may be marketed.
UCB Pharma SA
Allée de la Recherche 60
Date of first authorisation: 01 October 2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.